YaoGeJu

Company directoryChina company filings

Ningxia Kangya Pharmaceutical Co., Ltd.

As of 18 November 2026, for the company name Ningxia Kangya Pharmaceutical Co., Ltd. as recorded, the chemical-drug catalogue lists 2 active records with this name as holder; 8 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/18
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.

Drug filings

18 acceptance records as first applicant, grouped into 17 source drug names. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

盐酸氮?斯汀滴眼液 · No verified English name 1 records · Latest accepted 2026/10/28

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2602636Generic2026/10/28Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
YT628 · No verified English name 1 records · Latest accepted 2026/07/16

New drug · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHL2600859New drug2026/07/16Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Probucol Tablets 1 records · Latest accepted 2026/06/01

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601226Generic2026/06/01Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Flurbiprofen Sodium Eye Drops 1 records · Latest accepted 2026/04/08

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2600801Generic2026/04/08Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
氧氟沙星滴耳液 · No verified English name 1 records · Latest accepted 2025/10/18

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2503735Generic2025/10/18Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Bisoprolol Fumarate and Amlodipine Besylate Tablets 1 records · Latest accepted 2025/01/25

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500479Generic2025/01/25Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Iguratimod Tablets 1 records · Latest accepted 2025/01/15

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500290Generic2025/01/15Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Amlodipine Besylate Tablets 1 records · Latest accepted 2024/09/14

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2403097Generic2024/09/14Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Epalrestat Tablets 1 records · Latest accepted 2024/07/27

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2402372Generic2024/07/27Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Sodium Hyaluronate Eye Drops 2 records · Latest accepted 2023/10/09

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302642Generic2023/10/09Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
CYHS2302641Generic2023/10/09Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
核黄素磷酸钠滴眼液 · No verified English name 1 records · Latest accepted 2022/08/09

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2201261Generic2022/08/09Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
WJ-39片 · No verified English name 1 records · Latest accepted 2022/05/10

New drug · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHL2200287New drug2022/05/10Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
盐酸洛美沙星滴眼液 · No verified English name 1 records · Latest accepted 2022/01/21

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2200178Supplement2022/01/21Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Moxifloxacin Hydrochloride Eye Drops 1 records · Latest accepted 2022/01/11

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2200035Generic2022/01/11Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
盐酸左氧氟沙星滴眼液 · No verified English name 1 records · Latest accepted 2021/08/03

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2101650Supplement2021/08/03Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Meloxicam Tablets 1 records · Latest accepted 2021/07/24

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2150751Supplement2021/07/24Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Levofloxacin Eye Drops 1 records · Latest accepted 2021/01/09

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2100025Generic2021/01/09Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗

Changes in the last 90 days

1 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Accepted: 1 application

  1. 2026/10/28Accepted

    盐酸氮?斯汀滴眼液 · No verified English name

    CYHS2602636

    Fact date: 2026/10/28 · Date added to this site: 2026/10/29

    View source ↗

Under review

4 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
盐酸氮?斯汀滴眼液 · No verified English name CYHS2602636Generic2026/10/28Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Probucol Tablets CYHS2601226Generic2026/06/01Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Flurbiprofen Sodium Eye Drops CYHS2600801Generic2026/04/08Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
氧氟沙星滴耳液 · No verified English name CYHS2503735Generic2025/10/18Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗

Catalogue holder records

2 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Iguratimod TabletsNingxia Kangya Pharmaceutical Co., Ltd.Ningxia Kangya Pharmaceutical Co., Ltd.国药准字H202647002026/06/10Generic approved under the new chemical-drug registration classificationCDE ↗
Meloxicam TabletsNingxia Kangya Pharmaceutical Co., Ltd.Ningxia Kangya Pharmaceutical Co., Ltd.国药准字H200202222022/08/16Drug that passed quality-and-efficacy consistency evaluationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

8 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.

NameCompany / applicantRegistration numberStatusSource update dateView source
氟比洛芬钠 · No verified English nameNingxia Kangya Pharmaceutical Co., Ltd.Y20230001295A2025/09/22CDE ↗
依帕司他 · No verified English nameNingxia Kangya Pharmaceutical Co., Ltd.Y20230000822A2026/08/25CDE ↗
加替沙星 · No verified English nameNingxia Kangya Pharmaceutical Co., Ltd.Y20220000678I2023/12/19CDE ↗
羟苯磺酸钙 · No verified English nameNingxia Kangya Pharmaceutical Co., Ltd.Y20190008362A2024/11/07CDE ↗
兰索拉唑 · No verified English nameNingxia Kangya Pharmaceutical Co., Ltd.Y20190008173A2026/01/16CDE ↗
苄达赖氨酸 · No verified English nameNingxia Kangya Pharmaceutical Co., Ltd.Y20190006107A2026/01/16CDE ↗
苯磺酸氨氯地平 · No verified English nameNingxia Kangya Pharmaceutical Co., Ltd.Y20190006106A2026/01/16CDE ↗
美洛昔康 · No verified English nameNingxia Kangya Pharmaceutical Co., Ltd.Y20190001416A2024/03/02CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

29 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Sodium Hyaluronate Eye Drops CYHB2601692Supplement2026/09/07Ai Shi Pharmaceutical Co., Ltd. romanized; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Sodium Hyaluronate Eye Drops CYHB2601691Supplement2026/09/07Ai Shi Pharmaceutical Co., Ltd. romanized; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
小儿氨酚黄那敏颗粒 · No verified English name CYHB2601366Supplement2026/07/17Wuhan Yuan Pu Pharmaceutical Co., Ltd. romanized; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Polyvinyl Alcohol Eye Drops CYHB2601154Supplement2026/06/18Zhejiang Shi Fang Ji Pharmaceuticals Technology Co., Ltd. romanized; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Flurbiprofen Sodium Eye Drops CYHS2600747Generic2026/03/30Lang Tian Pharma (Hubei) Co., Ltd. romanized; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Calcium Dobesilate Tablets CYHS2504508Generic2025/12/31Beijing Kang Er Fu Pharma Co., Ltd. romanized; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Sodium Hyaluronate Eye Drops CYHB2501862Supplement2025/09/20Zhejiang Shi Fang Ji Pharmaceuticals Technology Co., Ltd. romanized; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Voriconazole for Oral Suspension CYHS2502967Generic2025/08/14Hebei Rong Lin Pharmaceutical Co., Ltd. romanized; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Sodium Hyaluronate Eye Drops CYHB2500697Supplement2025/04/08Chengdu Kanghong Pharmaceutical Group Co.,Ltd.; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Sodium Hyaluronate Eye Drops CYHB2500696Supplement2025/04/08Chengdu Kanghong Pharmaceutical Group Co.,Ltd.; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Sodium Hyaluronate Eye Drops CYHB2500695Supplement2025/04/08Chengdu Kanghong Pharmaceutical Group Co.,Ltd.; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Sodium Hyaluronate Eye Drops CYHB2500208Supplement2025/01/25Zhejiang Shi Fang Ji Pharmaceuticals Technology Co., Ltd. romanized; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Sodium Hyaluronate Eye Drops CYHB2500200Supplement2025/01/24Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Levofloxacin Eye Drops CYHB2500066Supplement2025/01/10Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd.; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Dapoxetine Hydrochloride Tablets CYHB2401872Supplement2024/11/12Hunan Qian Jin Xiang Jiang Pharma Co., Ltd. romanized; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Sodium Hyaluronate Eye Drops CYHB2401594Supplement2024/09/30Zhejiang Shi Fang Ji Pharmaceuticals Technology Co., Ltd. romanized; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Moxifloxacin Hydrochloride Eye Drops CYHB2401568Supplement2024/09/26Ai Shi Pharmaceutical Co., Ltd. romanized; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Sodium Cromoglicate Eye Drops CYHB2401289Supplement2024/08/20Changchun Zhang Qing Pharma Group Co., Ltd. romanized; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Moxifloxacin Hydrochloride Eye Drops CYHB2401080Supplement2024/07/20Ai Shi Pharmaceutical Co., Ltd. romanized; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Pheniramine Maleate Naphazoline Hydrochloride Eye Drops CYHS2401358Generic2024/05/08Zhejiang Shi Fang Ji Pharmaceuticals Technology Co., Ltd. romanized; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Levofloxacin Eye Drops CYHS2400515Generic2024/02/06Long Ji Chuan (Ningxia) Pharmaceuticals Technology Development Co., Ltd. romanized; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Azelastine Hydrochloride Eye Drops CYHS2400268Generic2024/01/19Guangzhou Shi Tong Hui Pharma Co., Ltd. romanized; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
维生素B1片 · No verified English name CYHB2302564Supplement2023/11/21Shandong He Xing Pharma Co., Ltd. romanized; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Sodium Hyaluronate Eye Drops CYHS2302374Generic2023/09/05Long Ji Chuan (Ningxia) Pharmaceuticals Technology Development Co., Ltd. romanized; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Dapoxetine Hydrochloride Tablets CYHS2301919Generic2023/07/17Wuhan Hua Er Bio Technology Co., Ltd. romanized; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Sodium Hyaluronate Eye Drops CYHS2301831Generic2023/07/07Chengdu Kanghong Pharmaceutical Group Co.,Ltd.; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Sodium Hyaluronate Eye Drops CYHS2300720Generic2023/03/07Zhejiang Shi Fang Ji Pharmaceuticals Technology Co., Ltd. romanized; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Calcium Dobesilate Tablets CYHS2201974Generic2022/11/14Zhejiang Shi Fang Ji Pharmaceuticals Technology Co., Ltd. romanized; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗
Metronidazole Tablets CYHB2200539Supplement2022/03/22Ningbo Shi Fang Pharmaceuticals Technology Co., Ltd. romanized; Ningxia Kangya Pharmaceutical Co., Ltd.CDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/18 · Current coverage may be incomplete
Chemical-drug catalogue
Last successful update: 2026/11/18
API registrations
Last successful update: 2026/11/18
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.